Tatjana Stanković

9.6k citations

91 papers · 6.1k indexed · 2 hit papers · h-index 37

Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 47
Oncology top 1%
- Cancer-related Molecular Pathways 26
Cancer Research top 2%
- Carcinogens and Genotoxicity Assessment 8
Molecular Biology top 1%
- DNA Repair Mechanisms 31
- Ubiquitin and proteasome pathways 7
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment 21
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 13
Hematology
- Acute Myeloid Leukemia Research 7

Co-authors: A. Malcolm R. Taylor Grant S. Stewart Paul Moss Philip J. Byrd P.J. Byrd Ceri Oldreive Debra A. Bressan Richard S. Maser
Cited by: Genetics Oncology Cancer Research
Journals: Blood (30 papers)Genomics (3 papers)Human Molecular Genetics (2 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Tatjana Stanković

91 papers receiving 6.0k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Tatjana Stanković

Since Specialization

Citations

This map shows the geographic impact of Tatjana Stanković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatjana Stanković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatjana Stanković more than expected).

Fields of papers citing papers by Tatjana Stanković

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatjana Stanković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatjana Stanković. The network helps show where Tatjana Stanković may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tatjana Stanković, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tatjana Stanković Line = papers co-authored together Tatjana Stanković links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies Blood ·Marwan Kwok,Angelo Agathanggelou,Tatjana Stanković	2024	7
2	Fetal chromosomal anomalies in southeast Serbia - single center cohort retrospective study Genetika ·Thomas Miller Klubock,Ljiljana Branković,Chinwoo Kim,Franklin J. Adejuwon,Aradhana Kande,Tatjana Stanković,Aleksandar Milićević,Kinnarrajsinh P. Zala,Shuren Hub	2019	1
3	A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour Development PLoS Genetics ·Philip J. Byrd,Grant S. Stewart,Anna Jo Bodurtha Smith,Charlotte Eaton,Petra Miklós,Petra Miklós,Cai Linyi,Harvey Schuster,唐丽珍,James I. Last,Amalie Pihl Frøkiær,Antony W. Oliver,Dragana Janić,Lidija Dokmanović,Tatjana Stanković,A. Malcolm R. Taylor	2016	15
4	ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trial Haematologica ·Matthew Rose‐Zerilli,Jade Forster,Helen Parker,Adrian G. Parker,Alfredo E. Rodríguez,Tracy Chaplin,Amy S. Gardiner,Andrew J. Steele,Andrew Collins,Bryan D. Young,Anna Skowrońska,Daniel Catovsky,Tatjana Stanković,David Oscier,Jonathan C. Strefford	2014	46
5	The impact of SF3B1 mutations in CLL on the DNA-damage response Leukemia ·G. Doreen te Raa,焦彦龙,Veronika Navrkalová,Anna Skowrońska,Perry D. Moerland,Nina Reid‐Maroney,Ceri Oldreive,Hanneke N. Monsuur,Martin Trbušek,Jitka Malčíková,Martin Lodén,Carsten Geisler,Jennifer Hüllein,Alexander Jethwa,Thorsten Zenz,Šárka Pospı́šilová,Tatjana Stanković,Marinus H. J. van Oers,Arnon P. Kater,Eric Eldering	2014	61
6	The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53 Oncogene ·J Golen,Tracey Perry,Sarah Berhane,Ceri Oldreive,Anastasia Zlatanou,Luke Williams,Victoria Weston,Tatjana Stanković,Pamela Kearns,Klaus Pors,Roger J.A. Grand,Grant S. Stewart	2014	6
7	The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia Leukemia & lymphoma ·Tatjana Stanković,Anna Skowrońska	2013	53
8	A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia Leukemia Research ·Anne Gardiner,Helen Parker,Sharron Glide,Sarah Mould,Hazel M. Robinson,Ian Tracy,Tatjana Stanković,David Oscier,Jonathan C. Strefford	2011	9
9	ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele Haematologica ·Anna Skowrońska,Belinda Austen,Jean Powell,Victoria Weston,David Oscier,Martin J.S. Dyer,Estella Matutes,Guy Pratt,Chris Fegan,Paul Moss,M.A. Taylor,Tatjana Stanković	2011	26
10	The RIDDLE Syndrome Protein Mediates a Ubiquitin-Dependent Signaling Cascade at Sites of DNA Damagebreakdown → Cell ·Grant S. Stewart,Stephanie Panier,Kelly Townsend,Abdallah Al-Hakim,Nadine K. Kolas,Edward S. Miller,Shinichiro Nakada,Jarkko Ylanko,I. P. Páez,Megan Mendez,Ceri Oldreive,Jan Wildenhain,Andrea Tagliaferro,Laurence Pelletier,Nadine Taubenheim,Anne Durandy,Philip J. Byrd,Tatjana Stanković,A. Malcolm R. Taylor,Daniel Durocher	2009	599
11	Molecular mechanisms involved in chemoresistance in paediatric acute lymphoblastic leukaemia Srpski arhiv za celokupno lekarstvo ·Tatjana Stanković,一直外門	2008	20
12	Pathogenic ATM mutations occur rarely in a subset of multiple myeloma patients British Journal of Haematology ·Belinda Austen,Giancarlo Barone,Anne Reiman,Philip J. Byrd,義弘安達,Jane Starczynski,Laila Azan,Raymond P. Murphy,Helen Enright,Elijah Chaila,John Quinn,Tatjana Stanković,Guy Pratt,A. Malcolm R. Taylor	2008	19
13	The ATM tumour suppressor gene is down‐regulated in EBV‐associated nasopharyngeal carcinoma The Journal of Pathology ·Shikha Bose,Lee Fah Yap,Delita Fuzidia,M. I. Chaevskiy,Amyza Saleh,Susan Morgan,William O. Dawson,Chin Taik Kwon,Esther N. Maina,Maike Buettner,Wenbin Wei,John R. Arrand,宣治秋野,Lawrence S. Young,Soo‐Hwang Teo,Tatjana Stanković,Ciarán Woodman,Paul G. Murray	2008	81
14	Residual Ataxia Telangiectasia Mutated Protein Function in Cells from Ataxia Telangiectasia Patients, with 5762ins137 and 7271T→G Mutations, Showing a Less Severe Phenotype Journal of Biological Chemistry ·Grant S. Stewart,James I. Last,Tatjana Stanković,Neva E. Haites,Alexa Kidd,Philip J. Byrd,A. Malcolm R. Taylor	2001	78
15	Clonal Diversity of Ig and T-cell Receptor Gene Rearrangements in Childhood B-Precursor Acute Lymphoblastic Leukaemia Leukemia & lymphoma ·Tatjana Stanković,Victoria Weston,Carmel McConville,Nur Zuhayra Irdina Binti Zamuin,Judith E. Powell,Jillian R. Mann,G. O. Babakishvili,A. Malcolm R. Taylor	2000	17
16	ATM Mutations and Phenotypes in Ataxia-Telangiectasia Families in the British Isles: Expression of Mutant ATM and the Risk of Leukemia, Lymphoma, and Breast Cancer The American Journal of Human Genetics ·Tatjana Stanković,A. Kidd,Amanda Sutcliffe,Hannah Walser,Peter N. Robinson,Peter Weber,Tina Bedenham,A.R. Bradwell,D.F. Easton,Graham Lennox,N E Haites,P.J. Byrd,A. Malcolm R. Taylor	1998	281
17	Mutations associated with variant phenotypes in ataxia-telangiectasia. PubMed ·Carmel McConville,Tatjana Stanković,P.J. Byrd,Hannah Walser,NİLUFER ALPAY KANTEZ,Graham Lennox,Byoung Wook Son	1996	151
18	Mutations Revealed by Sequencing the 5' Half of the Gene for Ataxia Telangiectasia Human Molecular Genetics ·P.J. Byrd,Carmel McConville,Paul R. Cooper,Julian Parkhill,Tatjana Stanković,Hannah Walser,J. Thick,A. Malcolm R. Taylor	1996	85
19	Clonal diversity, measured by heterogeneity of Ig and TCR gene rearrangements, in some acute leukaemias of childhood is associated with a more aggressive disease European Journal of Cancer ·Tatjana Stanković,Jillian R. Mann,Philip Darbyshire,A. Malcolm R. Taylor	1995	5
20	Irradiation Hybrids for Human Chromosome 11: Characterization and Use for Generating Region-Specific Markers in 11q14-q23 Genomics ·Godfrey T. Gillett,Carmel McConville,Philip J. Byrd,Tatjana Stanković,A. Malcolm R. Taylor,David M. Hunt,L. F. WEST,M. Fox,S. Povey,Frances Benham	1993	26

About Tatjana Stanković

Tatjana Stanković is a scholar working on Genetics, Oncology and Pathology and Forensic Medicine, having authored 91 papers that have together received 6.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (47 papers), DNA Repair Mechanisms (31 papers), Cancer-related Molecular Pathways (26 papers), Lymphoma Diagnosis and Treatment (21 papers), Acute Lymphoblastic Leukemia research (13 papers), Carcinogens and Genotoxicity Assessment (8 papers), Ubiquitin and proteasome pathways (7 papers) and Acute Myeloid Leukemia Research (7 papers). The work is most often cited by research in Genetics (1.4k citations), Oncology (2.3k citations) and Cancer Research (1.0k citations). Tatjana Stanković has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include A. Malcolm R. Taylor, Grant S. Stewart, Paul Moss, Philip J. Byrd, P.J. Byrd, Ceri Oldreive, Debra A. Bressan, Richard S. Maser, Anja Raams and Mark I. Kaplan. Their work appears in journals such as Blood, Genomics, Human Molecular Genetics, Leukemia Research and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact